Second, TNF-α/IL-1β pretreatment enhanced the efficacy of hADSCs in the improvement in hepatic function and liver fibrosis in BDL mice and increased the ability of hADSCs to inhibit HSC activation. Here, TNF is linked to Hepatic fibrosis.